WEE1 and neurodevelopmental disorder: Further exploration of the role of SDS22 and PP1 in the development of neurodevelopmental disorders is important, as it may provide avenues to treat disease progression, for example using inhibitors of protein kinases that act antagonistically to PP1, thereby restoring the phosphorylation balance of PP1 substrates.